Faron Pharmaceuticals Oy
Research Faron Pharmaceuticals Oy (FARON) on Bullrun: market cap EUR 98.19M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFARON
- ExchangeHE
- CountryFinland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 98.19M
- Financial periodFY2025
- Net income-EUR 27.26M
- Free cash flow-EUR 18.14M
Valuation Snapshot
latest market cap is EUR 98.19M.
About Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidate is Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation. It is also developing bexmarilimab for the treatment of hematological and solid tumor cancers;
Frequently asked questions
What is Faron Pharmaceuticals Oy's market cap?
Faron Pharmaceuticals Oy's market capitalization is EUR 98.19M.
What does Faron Pharmaceuticals Oy do?
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidate is Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like...